MoonLake Immunotherapeutics MLTX Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$230.32M-90.0% | -$121.24M-175% | -$44.08M+14.1% | -$51.33M+8.3% | ||
| $2.62M+88.9% | $1.39M+274% | $370K+125% | $164.78K— | ||
| $12.9M+77.1% | $7.28M+2.5% | $7.11M-26.4% | $9.65M— | ||
| -$196.01M-68.1% | -$116.59M-173% | -$42.78M+23.5% | -$55.89M+11.1% | ||
| —— | $520K+83.1% | $284K— | —— | ||
| —— | —— | —— | —— | ||
| —— | $0— | —— | —— | ||
| $146M+185% | $51.31M-89.3% | $479.7M+301% | $119.69M+67.3% | ||
| —— | —— | —— | —— | ||
| -$196.04M-67.4% | -$117.11M-172% | -$43.06M+23.0% | -$55.91M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does MoonLake Immunotherapeutics generate?
- MoonLake Immunotherapeutics (MLTX) generated -$224.2M in operating cash flow over the trailing twelve months.
- What is MoonLake Immunotherapeutics's free cash flow?
- After $343.0K of capital expenditures, MoonLake Immunotherapeutics's free cash flow was -$224.2M over the trailing twelve months, down 60.0% year over year.
- Where does MoonLake Immunotherapeutics's cash flow data come from?
- Every line is extracted from MoonLake Immunotherapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.